{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:42Z","timestamp":1787071002800,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To find out the simple relationship between Total Reference Air Kerma (TRAK) and various isodose volumes. Calculated isodose volumes were compared with experimental data for revised Manchester and International Commission on Radiation Units and measurements (ICRU)-89 Point A-based treatment plans. The accuracy of the formula was compared with the results of other relationships available in the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Dosimetric data from 62 intracavitary brachytherapy (ICBT) treatment plans of 31 patients with cervical cancer were studied. Each patient had treatment plans normalized to revised Manchester and ICRU-89 Points A (A\n                      <jats:sub>flange<\/jats:sub>\n                      and A\n                      <jats:sub>icru89<\/jats:sub>\n                      ). For each treatment plan, TRAK values, V\n                      <jats:sub>350,<\/jats:sub>\n                      V\n                      <jats:sub>700<\/jats:sub>\n                      , V\n                      <jats:sub>1050<\/jats:sub>\n                      , and V\n                      <jats:sub>1400<\/jats:sub>\n                      were obtained. The modeling curve was plotted between Isodose volume (V\n                      <jats:sub>d<\/jats:sub>\n                      ) and the ratio of d\/TRAK obtained from A\n                      <jats:sub>flange<\/jats:sub>\n                      plans to get a mathematical relation. The results of this formula were compared with the experimental data and outcomes of other formulas available in the literature. A paired-sample\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test was performed to assess the statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the case of revised Manchester-based A\n                      <jats:sub>flange<\/jats:sub>\n                      normalization plans, the mean isodose volume of V\n                      <jats:sub>350<\/jats:sub>\n                      , V\n                      <jats:sub>700<\/jats:sub>\n                      , V\n                      <jats:sub>1050,<\/jats:sub>\n                      and V\n                      <jats:sub>1400<\/jats:sub>\n                      were 285.98 \u00b1 32.3 cm\n                      <jats:sup>3<\/jats:sup>\n                      , 101.96 \u00b1 10.63 cm\n                      <jats:sup>3<\/jats:sup>\n                      , 52.71 \u00b1 4.72 cm\n                      <jats:sup>3<\/jats:sup>\n                      , and 31.44 \u00b1 2.33 cm\n                      <jats:sup>3<\/jats:sup>\n                      respectively. Likewise, for ICRU-89 based A\n                      <jats:sub>icru89<\/jats:sub>\n                      normalization plans, the mean isodose volumes of V\n                      <jats:sub>350<\/jats:sub>\n                      , V\n                      <jats:sub>700<\/jats:sub>\n                      , V\n                      <jats:sub>1050,<\/jats:sub>\n                      and V\n                      <jats:sub>1400<\/jats:sub>\n                      were 304.11 \u00b1 26.17 cm\n                      <jats:sup>3<\/jats:sup>\n                      , 108.88 \u00b1 8.29 cm\n                      <jats:sup>3<\/jats:sup>\n                      , 56.62 \u00b1 3.69 cm\n                      <jats:sup>3<\/jats:sup>\n                      and 34 \u00b1 2.23 cm\n                      <jats:sup>3<\/jats:sup>\n                      respectively. The mean difference was significant. The Mathematical relationship developed was [INLINE:1]. No correlation was found between TRAK and D\n                      <jats:sub>0.1cm<\/jats:sub>\n                      <jats:sup>3<\/jats:sup>\n                      ,D\n                      <jats:sub>2cm<\/jats:sub>\n                      <jats:sup>3<\/jats:sup>\n                      for organs at risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The developed formula calculated isodose volumes within the accuracy of \u00b1 3% in ICBT plans.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_47_21","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:07:26Z","timestamp":1675753646000},"page":"1105-1113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A mathematical model to predict the different isodose volumes using TRAK value in HDR intracavitary brachytherapy for revised Manchester and ICRU-89 based Point A plans using computer tomography images"],"prefix":"10.4103","volume":"18","author":[{"given":"Ankur","family":"Mourya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Pratap","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaganpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit Mohan","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20241021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/jcb.2016.59282","article-title":"Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer","volume":"8","author":"Wang","year":"2016","journal-title":"J Contemp Brachyther"},{"key":"R2-35-20241021","doi-asserted-by":"crossref","first-page":"386401","DOI":"10.3322\/caac.21578","article-title":"Brachytherapy: An overview for clinicians","volume":"69","author":"Chargari","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R3-35-20241021","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1016\/j.ijrobp.2011.01.022","article-title":"Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401\/JROSG04-2)","volume":"82","author":"Toita","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"R4-35-20241021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-0528.1936.tb12413.x","article-title":"The radiumhemmet method of treatment and results in cancer of the corpus of the uterus","volume":"43","author":"Heyman","year":"1936","journal-title":"BJOG"},{"key":"R5-35-20241021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00016925409174481","article-title":"The dosage distribution in the pelvis in radium treatment of carcinoma of the cervix","volume":"42","author":"Walstam","year":"1954","journal-title":"Acta Radiol"},{"key":"R6-35-20241021","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1148\/radiology.165.2.3659384","article-title":"Cervical cancer: Intracavitary dose specification and prescription","volume":"165","author":"Potish","year":"1987","journal-title":"Radiology"},{"key":"R7-35-20241021","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1259\/0007-1285-11-132-809","article-title":"A dosage system for use in the treatment of cancer of the uterine cervix","volume":"11","author":"Tod","year":"1938","journal-title":"Br J Radiol"},{"key":"R11-35-20241021","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1118\/1.1791352","article-title":"Determination of the reference air kerma rate for 192Ir brachytherapy sources and the related uncertainty","volume":"31","author":"Van Dijk","year":"2004","journal-title":"Med Phys"},{"key":"R12-35-20241021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1259\/0007-1285-26-305-252","article-title":"Treatment of cancer of the cervix uteri \u2013 A revised \u201cmanchester method.\u201d","volume":"26","author":"Tod","year":"1953","journal-title":"Br J Radiol"},{"key":"R13-35-20241021","first-page":"396","article-title":"The use of the \u201cManchester System\u201d for treatment of cancer of the uterine cervix with modern after-loading radium applicators","volume":"18","author":"Batley","year":"1967","journal-title":"J Can Assoc Radiol"},{"key":"R14-35-20241021","first-page":"17380","article-title":"\u201cFrom Point A to the Sculpted Pear: MR Image Guidance Significantly Improves Tumour Dose and Sparing of Organs at Risk in Brachytherapy of Cervical Cancer.\u201d","volume":"94","author":"Kari","year":"2010","journal-title":"Radiotherapy and Oncology"},{"key":"R15-35-20241021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-35-20241021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: General principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"R18-35-20241021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(00)00266-8","article-title":"Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy","volume":"58","author":"P\u00f6tter","year":"2001","journal-title":"Radiother Oncol"},{"key":"R19-35-20241021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1259\/0007-1285-62-736-362","article-title":"The ICRU recommendations for reporting intracavitary therapy in gynaecology and the manchester method of treating cancer of the cervix uteri","volume":"62","author":"Wilkinson","year":"1989","journal-title":"Br J Radiol"},{"key":"R20-35-20241021","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0360-3016(94)90077-9","article-title":"Treatment volume from Total Reference Air Kerma (TRAK) in intracavitory applications and its comparison with ICRU reference volume","volume":"28","author":"Deshpande","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-35-20241021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1538-4721(03)00096-5","article-title":"Total reference air kerma: To what extent can it predict intracavitary volume enclosed by isodose surfaces during multiple high-dose rate brachytherap","volume":"13","author":"Datta","year":"2003","journal-title":"Brachytherapy"},{"key":"R22-35-20241021","doi-asserted-by":"crossref","first-page":"118491","DOI":"10.1016\/j.brachy.2017.05.011","article-title":"Total reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study","volume":"16","author":"Nkiwane","year":"2017","journal-title":"Brachytherapy"},{"key":"R23-35-20241021","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.rpor.2019.09.014","article-title":"Formulation of normal tissue irradiation volumes in Co-60 and Ir-192 HDR ICBT of Ca cervix using Total Reference Air Kerma (TRAK)","volume":"24","author":"Robert","year":"2019","journal-title":"Reports Pract Oncol Radiother"},{"key":"R24-35-20241021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"R25-35-20241021","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiolo","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"R26-35-20241021","first-page":"1439","article-title":"Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy","volume":"8","author":"Hofbauer","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"R27-35-20241021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/jcm8010125","article-title":"Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy","volume":"8","author":"Bockel","year":"2019","journal-title":"J Clin Med"},{"key":"R28-35-20241021","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brachy.2020.08.016","article-title":"Letter to the editor on the research article \u201cTotal reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study\u201d","volume":"20","author":"Mourya","year":"2021","journal-title":"Brachytherapy"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_47_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:14Z","timestamp":1787067614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_47_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_47_21","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}